Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Pediatric Genomic Medicine, |
RCV000514561 | SCV000609538 | likely benign | not provided | 2017-04-17 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000608992 | SCV000730790 | benign | not specified | 2017-11-15 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000514561 | SCV001038312 | benign | not provided | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000514561 | SCV005215363 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Mayo Clinic Laboratories, |
RCV000514561 | SCV000802820 | uncertain significance | not provided | 2016-03-11 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003902819 | SCV004720469 | benign | ATP5F1A-related disorder | 2019-10-29 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |